medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2025, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2025; 23 (2)

Desmoid tumor, a diagnostic challenge

Quijada UZM, Quijada UEE
Full text How to cite this article

Language: Spanish
References: 6
Page: 124-128
PDF size: 215.10 Kb.


Key words:

deep fibromatosis, desmoid tumor, radiotherapy, immunohistochemistry.

ABSTRACT

Desmoid tumors (DT), also known as aggressive fibromatosis, are rare soft tissue neoplasms originating from fibroblasts. Characterized by locally invasive growth without metastasis, they can affect adjacent organs and structures, significantly impacting patients’ quality of life. These tumors are uncommon, with a low incidence and a predilection for women around 35 years of age. Diagnosis can be challenging due to their variable morphology and clinical presentation.
We report the case of a 38-year-old female patient with a chronic dermatosis on her left shoulder, presenting as a deep-seated solid neoformation associated with pain and erythematous-violaceous skin changes. Immunohistochemical analysis confirmed the diagnosis of dt, which was treated with wide surgical excision and adjuvant radiotherapy.
Due to their infiltrative nature and high risk of recurrence, these neoplasms necessitate a multidisciplinary approach. Immunohistochemistry plays a crucial role in diagnosis, and treatment should be individualized given the absence of standardized protocols.


REFERENCES

  1. Bektas M, Bell T, Khan S, Tumminello B, Fernández MM, HeyesC et al., Desmoid tumors: a comprehensive review, Adv Ther 2023; 40(9):3697-3722. Disponible en: https://doi.org/10.1007/s12325-023-02592-0.

  2. Brener-Chaoul M, Cervantes-Gutiérrez Ó, Padilla-Longoria R yMartín-Téllez KS, Tumores desmoides: consideraciones diagnóstico-terapéuticas, Gac Med Mex 2020; 156(5). Disponibleen: https://doi.org/10.24875/gmm.20000027.

  3. Sánchez-Mete L, Ferraresi V, Caterino M, Martayan A, TerrenatoI, Mannisi E et al., Desmoid tumors characteristics, clinical management,active surveillance, and description of our fap caseseries, J Clin Med 2020; 9(12):4012. Disponible en: https://doi.org/10.3390/jcm9124012.

  4. El Qadiri Y, El Adaoui O, El Andaloussi Y, Haddoun AR, BennounaD y Fadili M, Rare localisation of a recurrent desmoid tumour ofthe foot: a case report and review of the literature, Int J SurgCase Rep 2024; 118(109370):109370. Disponible en: https://doi.org/10.1016/j.ijscr.2024.109370.

  5. Riedel RF y Agulnik M, Evolving strategies for management ofdesmoid tumor, Cancer 2022; 128(16):3027-40. Disponible en:https://doi.org/10.1002/cncr.34332.

  6. Master SR, Mangla A y Shah C, Desmoid tumor, StatPearls2024. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK459231/.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2025;23